Jensen Investment Management’s Quest Diagnostics DGX Stock Holding History

Jensen Investment Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-8,070	Closed	-$490K	–	102
2014 Q3	$490K	Sell	8,070 -60	-0.7%	-$3.7K	0.01%	60
2014 Q2	$477K	Sell	8,130 -1,860	-19%	-$109K	0.01%	59
2014 Q1	$579K	Buy	9,990 +1,940	+24%	+$104K	0.01%	38
2013 Q4	$431K	Buy	8,050 +400	+5%	+$23.7K	0.01%	77
2013 Q3	$473K	Sell	7,650 -1,281	-14%	-$76.7K	0.01%	45
2013 Q2	$541K	Buy	+8,931	New	+$532K	0.01%	53

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Jensen Investment Management's DGX Position: Q4 2014 in Review

Jensen Investment Management sold out of Quest Diagnostics (DGX) in Q4 2014, closing a stake of 8,070 shares — an estimated $490K sold.

Jensen Investment Management first reported a position in DGX in Q2 2013 and held it in 6 quarters. The position peaked at $579K in Q1 2014. 517 funds tracked by Wall St. Rank hold DGX as of Q4 2014.

Jensen Investment Management reported no remaining Quest Diagnostics position as of Q4 2014 after selling out during the quarter.
Jensen Investment Management sold 8,070 Quest Diagnostics shares in Q4 2014, an estimated $490K.
Jensen Investment Management first reported a position in Quest Diagnostics in Q2 2013 and held it in 6 quarters.
Jensen Investment Management's Quest Diagnostics position peaked at $579K in Q1 2014.
517 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2014.

Based on Jensen Investment Management's 13F filing for Q4 2014, filed 29 Jan 2015.